Aurobindo Recalls Children's Ibuprofen Suspension Due to Missing Dosing Cups
Aurobindo Pharma USA Inc. is recalling 7,440 bottles of Children's Ibuprofen Oral Suspension because the product is missing dosing cups.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences. The issue is a packaging/labeling defect (missing dosing cups) rather than a contamination or safety hazard.
Plain-English summary
Aurobindo Pharma USA Inc. is recalling 7,440 bottles of Children's Ibuprofen Oral Suspension USP 100 mg per 5 mL, Berry Flavor, 4 fl oz (120 mL). The product is distributed by Chalkboard Health Inc. and was distributed in New Jersey. The specific lot number is BO1020080AA3 with an expiration date of 7/2023.
The recall was initiated because the product is missing dosing cups. This is a labeling issue classified by the FDA as Class III, which indicates that use of or exposure to the violative product is not likely to cause adverse health consequences.
Consumers who have this product should stop using it and contact the manufacturer or retailer for a refund or replacement. The product is an over-the-counter pain reliever and fever reducer intended for children.
The recalled product
- Product
- CHILDRENS IBUPROFEN (IBUPROFEN)
- Brand
- CHILDRENS IBUPROFEN
- Manufacturer
- Aurobindo Pharma USA Inc.
- Category
- Drug — OTC Pain Reliever
- Affected units
- 7,440
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # BO1020080AA3
- EXP 7/2023
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Aurobindo Pharma USA Inc.
See all →- ModerateDicyclomine Hydrochloride Capsules Recalled for Empty Capsules
FDA (Drugs) · 2026-08-12
- ModerateAmazon Basic Care Acetaminophen 325 mg Tablets Recalled Due to Discoloration
FDA (Drugs) · 2025-06-25
- HighPrescription drug recall: Aurobindo Nebivolol tablets contain excess nitrosamine impurity
FDA (Drugs) · 2024-12-25
- HighFDA Recalls Cinacalcet 30mg Tablets for N-nitroso Impurity
FDA (Drugs) · 2024-12-11
- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding FDA Safety Limit
FDA (Drugs) · 2024-12-11
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02